Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 249

1.

Kuopio birth cohort - design of a Finnish joint research effort for identification of environmental and lifestyle risk factors for the wellbeing of the mother and the newborn child.

Huuskonen P, Keski-Nisula L, Heinonen S, Voutilainen S, Tuomainen TP, Pekkanen J, Lampi J, Lehto SM, Haaparanta H, Elomaa AP, Voutilainen R, Backman K, Kokki H, Kumpulainen K, Paananen J, Vähäkangas K, Pasanen M.

BMC Pregnancy Childbirth. 2018 Sep 21;18(1):381. doi: 10.1186/s12884-018-2013-9.

2.

The association between gestational diabetes mellitus and postpartum depressive symptomatology: A prospective cohort study.

Ruohomäki A, Toffol E, Upadhyaya S, Keski-Nisula L, Pekkanen J, Lampi J, Voutilainen S, Tuomainen TP, Heinonen S, Kumpulainen K, Pasanen M, Lehto SM.

J Affect Disord. 2018 Dec 1;241:263-268. doi: 10.1016/j.jad.2018.08.070. Epub 2018 Aug 15.

PMID:
30138811
3.

Peroxisome proliferator activated receptor gamma (PPAR-γ) ligand pioglitazone regulated gene networks in term human primary trophoblast cells.

El Dairi R, Huuskonen P, Pasanen M, Rysä J.

Reprod Toxicol. 2018 Oct;81:99-107. doi: 10.1016/j.reprotox.2018.07.077. Epub 2018 Jul 19.

PMID:
30031879
4.

New glutathione conjugate of pyrrolizidine alkaloids produced by human cytosolic enzyme-dependent reactions in vitro.

Muluneh F, Häkkinen MR, El-Dairi R, Pasanen M, Juvonen RO.

Rapid Commun Mass Spectrom. 2018 Aug 30;32(16):1344-1352. doi: 10.1002/rcm.8173.

PMID:
29788543
5.

Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives.

Niinivehmas S, Postila PA, Rauhamäki S, Manivannan E, Kortet S, Ahinko M, Huuskonen P, Nyberg N, Koskimies P, Lätti S, Multamäki E, Juvonen RO, Raunio H, Pasanen M, Huuskonen J, Pentikäinen OT.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):743-754. doi: 10.1080/14756366.2018.1452919.

6.

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors.

Rauhamäki S, Postila PA, Niinivehmas S, Kortet S, Schildt E, Pasanen M, Manivannan E, Ahinko M, Koskimies P, Nyberg N, Huuskonen P, Multamäki E, Pasanen M, Juvonen RO, Raunio H, Huuskonen J, Pentikäinen OT.

Front Chem. 2018 Mar 2;6:41. doi: 10.3389/fchem.2018.00041. eCollection 2018.

7.

Environmental Intolerance, Symptoms and Disability Among Fertile-Aged Women.

Vuokko A, Karvala K, Lampi J, Keski-Nisula L, Pasanen M, Voutilainen R, Pekkanen J, Sainio M.

Int J Environ Res Public Health. 2018 Feb 8;15(2). pii: E293. doi: 10.3390/ijerph15020293.

8.

Genome sequence of the model plant pathogen Pectobacterium carotovorum SCC1.

Niemi O, Laine P, Koskinen P, Pasanen M, Pennanen V, Harjunpää H, Nykyri J, Holm L, Paulin L, Auvinen P, Palva ET, Pirhonen M.

Stand Genomic Sci. 2017 Dec 20;12:87. doi: 10.1186/s40793-017-0301-z. eCollection 2017.

9.

Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies.

Mustonen EK, Palomäki T, Pasanen M.

Regul Toxicol Pharmacol. 2017 Nov;90:328-341. doi: 10.1016/j.yrtph.2017.09.028. Epub 2017 Sep 29.

PMID:
28966105
10.

Molecular targets of chloropicrin in human airway epithelial cells.

Pesonen M, Rysä J, Storvik M, Rilla K, Pasanen M, Vähäkangas K.

Toxicol In Vitro. 2017 Aug;42:247-254. doi: 10.1016/j.tiv.2017.05.003. Epub 2017 May 3.

PMID:
28476498
11.

A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine.

Puris E, Pasanen M, Gynther M, Häkkinen MR, Pihlajamäki J, Keränen T, Honkakoski P, Raunio H, Petsalo A.

Anal Bioanal Chem. 2017 Jan;409(1):251-268. doi: 10.1007/s00216-016-9994-x. Epub 2016 Oct 12.

PMID:
27734142
12.
13.

The human placental proteome is affected by maternal smoking.

Huuskonen P, Amezaga MR, Bellingham M, Jones LH, Storvik M, Häkkinen M, Keski-Nisula L, Heinonen S, O'Shaughnessy PJ, Fowler PA, Pasanen M.

Reprod Toxicol. 2016 Aug;63:22-31. doi: 10.1016/j.reprotox.2016.05.009. Epub 2016 May 14.

14.

Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.

van der Laan JW, Kasper P, Silva Lima B, Jones DR, Pasanen M.

Crit Rev Toxicol. 2016 Aug;46(7):587-614. doi: 10.3109/10408444.2016.1163664. Epub 2016 Apr 26.

PMID:
27116466
15.

Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.

Hyvönen MT, Ucal S, Pasanen M, Peräniemi S, Weisell J, Khomutov M, Khomutov AR, Vepsäläinen J, Alhonen L, Keinänen TA.

Biochem J. 2016 May 15;473(10):1433-41. doi: 10.1042/BCJ20160134. Epub 2016 Mar 21.

PMID:
27001865
16.

Cytotoxicity of Oxycodone and Morphine in Human Neuroblastoma and Mouse Motoneuronal Cells: A Comparative Approach.

Kokki M, Pesonen M, Vehviläinen P, Litmala O, Pasanen M, Kokki H.

Drugs R D. 2016 Jun;16(2):155-63. doi: 10.1007/s40268-016-0125-0.

17.

Comparison of in vitro metabolism and cytotoxicity of capsaicin and dihydrocapsaicin.

Halme M, Pesonen M, Salo H, Söderström M, Pasanen M, Vähäkangas K, Vanninen P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 15;1009-1010:17-24. doi: 10.1016/j.jchromb.2015.11.042. Epub 2015 Nov 25.

PMID:
26688344
18.

Applying human and pig hepatic in vitro experiments for sulfur mustard study: screening and identification of metabolites by liquid chromatography/tandem mass spectrometry.

Halme M, Pesonen M, Hakala U, Pasanen M, Vähäkangas K, Vanninen P.

Rapid Commun Mass Spectrom. 2015 Jul 30;29(14):1279-87. doi: 10.1002/rcm.7218.

PMID:
26405789
19.

Species-Specific Differences in the in Vitro Metabolism of Lasiocarpine.

Fashe MM, Juvonen RO, Petsalo A, Räsänen J, Pasanen M.

Chem Res Toxicol. 2015 Oct 19;28(10):2034-44. doi: 10.1021/acs.chemrestox.5b00253. Epub 2015 Oct 2.

PMID:
26395423
20.

Transcriptomic Analysis of Human Primary Bronchial Epithelial Cells after Chloropicrin Treatment.

Pesonen M, Storvik M, Kokkola T, Rysä J, Vähäkangas K, Pasanen M.

Chem Res Toxicol. 2015 Oct 19;28(10):1926-35. doi: 10.1021/acs.chemrestox.5b00123. Epub 2015 Sep 17.

PMID:
26352163

Supplemental Content

Loading ...
Support Center